‘So resonant’: the 19th-century Russian opera being revived across Europe
Australia’s social media ban is attracting global praise – but we’re no closer to knowing how it would work
Daylight saving is about to end – and businesses on NSW-Queensland border are celebrating
Trump announces sweeping new tariffs, upending decades of US trade policy
Meta faces £1.8bn lawsuit over claims it inflamed violence in Ethiopia
‘So resonant’: the 19th-century Russian opera being revived across Europe
Australia’s social media ban is attracting global praise – but we’re no closer to knowing how it would work
Daylight saving is about to end – and businesses on NSW-Queensland border are celebrating
Trump announces sweeping new tariffs, upending decades of US trade policy
Meta faces £1.8bn lawsuit over claims it inflamed violence in Ethiopia
Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business
AstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up during the Covid pandemic.
Britain’s biggest drugmaker has agreed to take over the Seattle-based company Icosavax, which is developing a potential vaccine for two common respiratory diseases.
Notifications
More Stories
Newborns treated with antibiotics respond less well to vaccines, study shows
As a geneticist, I will not mourn 23andMe and its jumble of useless health information | Adam Rutherford
23andMe’s demise is a warning: the US needs to overhaul genetic data protection | Dalton Conley